http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-518682-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a48132fcc2f50a7107021f911f887cb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate | 2000-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4db7f7710cb9185b8591eca217ebd6b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36e53229f3e047b0d86fcc4bcd742a07 |
| publicationDate | 2003-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-518682-A |
| titleOfInvention | 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| abstract | A compound of formula (I), wherein; R1 is hydrogen, C1-6alkyl, haloC1-6alkyl, or a phenyl optionally substituted by one or more substituents selected from C1-4alkyl, halogen, haloC1-4alkyl, hydroxy, C1-4alkoxy, amino, mono- or di-C1-4alkylamino, C1-4alkylcarbonylamino, C1-4alkylthiocarbonylamino, C14alkoxycarbonylamino, C1-4alkoxythiocarbonylamino, C1-4alkylsulfonyl, C14alkylsulfonylamino, methylenedioxy, nitro and cyano, R2 is C1-6alkyl, C3-8cycloalkyl, phenyl or phenylC1-4alkyl in which the phenyl is optionally substituted by one or more substituents selected from C1-4alkyl, halogen, haloC1-4alkyl, hydroxy, C1-4alkoxy, amino, mono- or di-C1-4alkylamino, C1-4alkylcarbonylamino, C14alkylthiocarbonylamino, C1-4alkoxycarbonylamino, C1-4alkoxythiocarbonylamino, C14alkylsulfonyl, C1-4alkylsulfonylamino, methylenedioxy, nitro, cyano, or a 5 or 6-membered monocyclic or 9 or 10-membered bicyclic aromatic heterocycle containing one or two heteroatoms chosen from N, S and O, R3 is hydrogen, halogen, hydroxy, C1-6alkoxy, amino, mono- or di-C1-6alkylamino, C16alkylcarbonylamino, C1-6alkylthiocarbonylamino, C1-6alkoxycarbonylamino, C16alkoxythiocarbonylamino, nitro, or cyano, R4 is C1-6alkyl, amino, mono- or di-C1-6alkylamino, C1-6alkylcarbonylamino, C16alkylthiocarbonylamino, C1-6alkoxycarbonylamino, or C1-6alkoxythiocarbonylamino. Also described is the use of compounds of formula (I) in the manufacture of a medicament for use in treating cyclooxygenase-mediated diseases advantageously treated by an agent that selectively inhibits COX-2 in preference to COX-1. |
| priorityDate | 1999-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.